Drugmakers join fight over the 340B rebate pilot
Published
AbbVie, Bristol Myers Squibb, Boehringer Ingelheim and the industry group PhRMA asked to join the hospital lawsuit over HHS's plan to swap upfront drug discounts for after-the-fact rebates. Hospitals that serve many low-income patients are suing to stop the change.
Source: Healthcare Dive
This is a plain-language summary. Read the original source for full details.